Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
University of Florida
Essen Biotech
Perspective Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
Shasqi, Inc.
Hadassah Medical Organization
Sensei Biotherapeutics, Inc.
Incyte Corporation
University of California, Irvine
Roswell Park Cancer Institute
OncoC4, Inc.
Esperas Pharma Inc.
Deciphera Pharmaceuticals, LLC
Cyteir Therapeutics, Inc.
Mundipharma Research Limited
NantCell, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
Genmab
City of Hope Medical Center
Kineta Inc.
NKGen Biotech, Inc.
Daiichi Sankyo
Mirror Biologics, Inc.
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
Duke University
University of Kentucky
European Organisation for Research and Treatment of Cancer - EORTC
AGO Study Group
Fred Hutchinson Cancer Center